Outpace Bio Funding: $200M Raised, Series A (2024)
Outpace Bio is a Biotech company based in Seattle, Country. It has raised $200M in total funding. Latest round: Series A.
Outpace Bio funding overview
Outpace Bio is a Biotech company based in Seattle, Country. Outpace Bio has raised $200M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in August 2024. The round record for Outpace Bio runs through 2024; nothing later has been disclosed. Investors on record include Lyell Immunopharma, ARTIS Ventures. 2 distinct backers are named across the disclosed rounds.
Outpace Bio at a glance
Total raised
$200M
Latest round
Series A
Latest round date
August 2024
Industry
Biotech
Headquarters
Seattle, Country
Notable investors
Lyell Immunopharma, ARTIS Ventures
Frequently asked about Outpace Bio funding
How much has Outpace Bio raised?
Outpace Bio has raised $200M in total disclosed funding across the rounds on record.
Who has invested in Outpace Bio?
Lyell Immunopharma, ARTIS Ventures are named among the investors backing Outpace Bio.
What was the latest Outpace Bio funding round?
The most recent disclosed round is a Series A, announced in August 2024.
Where is Outpace Bio based?
Outpace Bio is based in Seattle, Country.
What sector does Outpace Bio operate in?
Outpace Bio is tracked under Biotech from Seattle, Country, with $200M in disclosed funding.
When did Outpace Bio last raise?
The last disclosed Outpace Bio round closed in August 2024 at Series A.
Every Outpace Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Seattle at a similar stage.
